About Medpace
Medpace (NASDAQ:MEDP) is a full-service clinical contract research organization (CRO) that serves the pharmaceutical, biotechnology, and medical device industries. With a global reach and a comprehensive suite of services, Medpace is committed to accelerating the development of safe and effective medical therapies. The company specializes in the management of clinical trials from protocol development through to FDA or EMA submission. Their expertise spans across multiple therapeutic areas, including oncology, cardiovascular, metabolic diseases, and more. Medpace’s objective is to support its clients in bringing innovative treatments to market as efficiently and effectively as possible, ensuring the highest standards of clinical research are maintained.
Snapshot
Operations
Products and/or services of Medpace
- Full-service clinical research services, offering Phase I-IV clinical trial management for drug and medical device development.
- Laboratory services, including central labs for clinical trials, bioanalytical testing, and biomarker development.
- Medical affairs services, providing medical writing, regulatory support, and safety monitoring for clinical research.
- Clinical pharmacology unit located in Cincinnati, specializing in early phase and bioequivalence studies.
- Data management and biostatistics services, offering electronic data capture, statistical analysis, and regulatory submission support.
- Consulting services for clinical development strategy, covering regulatory strategy, drug development planning, and project management.
Medpace executive team
- Dr. August James Troendle M.D.Chairman & CEO
- Mr. Jesse J. Geiger BBA, CPAPresident
- Mr. Kevin M. BradyCFO & Treasurer
- Ms. Susan E. Burwig BSN, MAExecutive Vice President of Operations
- Mr. Stephen P. Ewald J.D.Chief Compliance Officer, General Counsel & Corporate Secretary
- Mr. Brandon EbkenChief Information Officer
- Ms. Lauren MorrisAssociate Director of Investors Relations
- Mr. Todd MeyersVice President of Business Development & Marketing
- Mr. Weimin Gai MSSenior Vice President of Biometrics
- Mr. John T. Wynne MBASenior Vice President of Commercial Operations & Clinical Pharmacology Unit